Itzia Jimenez

Doctoral Student
More filtering options
  1. 2019
  2. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

    Boza-Serrano, A., Ruiz, R., Sanchez-Varo, R., García-Revilla, J., Yang, Y., Jimenez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D., Davila, J. C., Stegmayr, J., Jiménez, S., Roca-Ceballos, M. A., Navarro-Garrido, V., Swanberg, M., Hsieh, C. L., Real, L. M., Englund, E., Linse, S. & 7 othersHakon Leffler, Ulf J. Nilsson, Brown, G. C., Gutierrez, A., Vitorica, J., Venero, J. L. & Tomas Deierborg, 2019 Apr 20, In : Acta Neuropathologica.

    Research output: Contribution to journalArticle

  3. 2018
  4. Immunogenetics of Parkinson's disease

    Maria Swanberg & Itzia Jimenez-Ferrer, 2018 Dec 21, Parkinson’s Disease : Pathogenesis and Clinical Aspects. Stoker, T. B. & Greenland, J. C. (eds.). Brisbane (AU): Codon Publications, p. 27-44

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  5. Glutathione S-transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of Parkinson's disease

    Jewett, M., Dickson, E., Brolin, K., Negrini, M., Itzia Jimenez-Ferrer & Maria Swanberg, 2018 Apr 6, In : Frontiers in Neurology. 9, APR, 222.

    Research output: Contribution to journalArticle

  6. 2017
  7. Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism

    Puschmann, A., Fiesel, F. C., Caulfield, T. R., Hudec, R., Ando, M., Truban, D., Hou, X., Ogaki, K., Heckman, M. G., James, E. D., Swanberg, M., Jimenez Ferrer Carrillo, I., Hansson, O., Opala, G., Siuda, J., Boczarska-Jedynak, M., Friedman, A., Koziorowski, D., Aasly, J. O., Lynch, T. & 12 othersMellick, G. D., Mohan, M., Silburn, P. A., Sanotsky, Y., Vilariño-Güell, C., Farrer, M. J., Chen, L., Dawson, V. L., Dawson, T. M., Wszolek, Z. K., Ross, O. A. & Springer, W., 2017 Jan, In : Brain. 140, 1, p. 98-117

    Research output: Contribution to journalArticle

  8. Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder

    Puschmann, A., Fiesel, F. C., Caulfield, T. R., Hudec, R., Ando, M., Truban, D., Hou, X., Ogaki, K., Heckman, M. G., James, E. D., Swanberg, M., Jimenez-Ferrer, I., Hansson, O., Opala, G., Siuda, J., Boczarska-Jedynak, M., Friedman, A., Koziorowski, D., Rudzińska-Bar, M., Aasly, J. O. & 13 othersLynch, T., Mellick, G. D., Mohan, M., Silburn, P. A., Sanotsky, Y., Vilarinõ-Güell, C., Farrer, M. J., Chen, L., Dawson, V. L., Dawson, T. M., Wszolek, Z. K., Ross, O. A. & Springer, W., 2017, In : Brain. 140, 6, p. e33

    Research output: Contribution to journalLetter

  9. 2016
  10. Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease

    Kurowska, Z., Jewett, M., Per Ludvik Brattås, Itzia Jimenez, Kenéz, X., Tomas Björklund, Nordström, U., Brundin, P. & Maria Swanberg, 2016 Aug 23, In : Scientific Reports. 6, 31701.

    Research output: Contribution to journalArticle